Enanta Pharmaceuticals
ENTA
#8151
Rank
โ‚น34.91 B
Marketcap
โ‚น1,199
Share price
5.13%
Change (1 day)
-10.83%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -โ‚น4.61 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น65.25 Million. In 2025 the company made an earning of -โ‚น6.14 Billion, an increase over its 2024 earnings that were of -โ‚น9.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น4.61 Billion-24.93%
2025 -โ‚น6.14 Billion-34.07%
2024 -โ‚น9.31 Billion-23.87%
2023 -โ‚น12.23 Billion4.39%
2022 -โ‚น11.72 Billion-4.4%
2021 -โ‚น12.26 Billion91.12%
2020 -โ‚น6.42 Billion-407.13%
2019 โ‚น2.08 B-78.63%
2018 โ‚น9.77 B117.97%
2017 โ‚น4.48 B-574.65%
2016 -โ‚น0.95 Billion-110.83%
2015 โ‚น8.72 B-4.5%
2014 โ‚น9.13 B-638.53%
2013 -โ‚น1.7 Billion-137.98%
2012 โ‚น4.46 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.515 T-52,291.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.489 T-31,011.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
โ‚น834.86 B-17,423.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น484.07 B-10,144.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น738.03 B-15,414.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.143 T-23,818.01%๐Ÿ‡บ๐Ÿ‡ธ USA